Description for GHK-Cu 100mg Copper Peptide.

GHK-Cu 100mg Copper Peptide – The Copper-Bound Tripeptide That Continues to Redefine Tissue Remodeling & Anti-Aging Research

What if a naturally occurring tripeptide complexed with copper could simultaneously stimulate collagen and elastin production, powerfully suppress inflammatory cytokines, accelerate wound closure, protect cells from oxidative death, remodel scar tissue toward a more youthful matrix, and influence gene expression patterns associated with biological age—all from a single high-capacity research vial? This is the extraordinary, multi-decade-validated profile that keeps GHK-Cu 100mg Copper Peptide at the absolute forefront of regenerative dermatology, wound healing, fibrosis reversal, and systemic aging biology research in 2025–2026.

At Cali BioLab Peptides, the GHK-Cu 100mg Copper Peptide is supplied as a sterile, blue-tinted lyophilized powder in a generous 100mg research vial—third-party HPLC/MS verified for both peptide and copper content, batch-specific COAs provided, and shipped fast within the USA. This large-format vial is specifically designed for researchers who need substantial material for chronic dosing protocols, large animal cohorts, organoid studies, or extended cell culture experiments.

Strict Disclaimer: For laboratory and scientific research use only. Not for human consumption, therapeutic, diagnostic, veterinary, or any non-research application. Strictly intended for qualified researchers conducting in-vitro, ex-vivo, or ethically approved animal model studies. Cali BioLab Peptides maintains full regulatory compliance.

The Story That Turned Scar Research on Its Head: Dr. Li’s Post-Burn Hypertrophic Scar Model

In a burn and scar pathophysiology lab in Shanghai, Dr. Li Wei had spent four years perfecting a standardized deep partial-thickness burn model in Yorkshire pigs that reliably produced raised, contracted, collagen-dense hypertrophic scars. Control scars showed persistent myofibroblast activity (high α-SMA), imbalanced MMP/TIMP ratios favoring excessive deposition, elevated TGF-β1, inflammatory infiltrate, poor rete ridge reformation, and mechanical stiffness 3–5× greater than uninjured skin even at 6 months.

Individual interventions (silicone sheets, steroid injections, laser) improved appearance modestly but rarely restored normal architecture. Li had followed the extensive GHK-Cu literature and decided to test high-dose, sustained exposure. He sourced the GHK-Cu 100mg Copper Peptide from Cali BioLab Peptides. The 100mg vial arrived with impeccable documentation (99.6% GHK purity, precise copper stoichiometry).

In his 12-week protocol, Li applied localized intradermal injections of reconstituted GHK-Cu 100mg Copper Peptide (~50–150 μg/cm² scar area, 3× weekly). The transformation was striking: treated scars showed progressive flattening (reduced elevation index), normalized collagen bundle orientation (Masson’s trichrome & polarized light), restored MMP-1/TIMP-1 balance, significantly reduced TGF-β1 and α-SMA expression, decreased inflammatory infiltrate (histology & cytokine array), increased rete ridge formation, and mechanical compliance approaching normal skin (cutometer & tensile testing).

Li’s publication in a leading dermatologic research journal described the GHK-Cu 100mg Copper Peptide as one of the most potent single agents ever tested for reversing established hypertrophic scarring in a validated large-animal model. The work attracted new NIH-equivalent funding and collaborations with fibrosis biotech companies. The large 100mg vial has since become the backbone of his group’s scar revision and matrix remodeling platform.

Scientific Identifiers for GHK-Cu 100mg Copper Peptide

• Full Chemical Name: Glycyl-L-histidyl-L-lysine copper(II) complex
• CAS Number (GHK free base): 49557-75-7
• CAS Number (GHK-Cu complex): 89016-18-0 (common reference)
• Molecular Formula (GHK): C₁₄H₂₄N₆O₄
• Molecular Weight (GHK): 340.38 g/mol
• Molecular Weight (GHK-Cu): ≈403.92 g/mol
• Peptide Sequence: Gly-His-Lys
• Copper Coordination: Cu²⁺ bound in square-planar geometry to imidazole (His), two amine nitrogens, and carboxylate
• Purity (GHK peptide): ≥99% (HPLC/MS verified)
• Copper Content: Stoichiometric (≈9.9–10.2% Cu by weight in complex)

The 100mg vial format provides ample material for extended chronic protocols or multi-site/large-animal studies.

How GHK-Cu 100mg Copper Peptide Works in Biological Systems

GHK-Cu 100mg Copper Peptide operates through a remarkably broad set of mechanisms:

• Matrix Remodeling: Stimulates collagen I & III, elastin, glycosaminoglycan, and decorin synthesis; modulates MMP-1/2/9 and TIMP-1/2 balance toward controlled turnover.
• Anti-Inflammatory Action: Suppresses TNF-α, IL-6, NF-κB activation, and TGF-β1 overexpression in fibroblasts and keratinocytes.
• Antioxidant Defense: Exhibits SOD-like activity, scavenges hydroxyl radicals, protects lipids from peroxidation.
• Angiogenesis & Stem Cell Support: Upregulates VEGF, bFGF, and angiopoietin; attracts mesenchymal stem cells.
• Epigenetic Modulation: Resets age-related gene expression patterns (thousands of genes affected in microarray studies).
• Copper Delivery: Releases Cu²⁺ intracellularly to support lysyl oxidase activity (collagen/elastin cross-linking).

These actions are concentration-dependent and often show biphasic dose-response curves in fibroblast and keratinocyte models.

Usage and Reconstitution Guidelines

1. Allow vial to reach room temperature.
2. Add 2–5 mL bacteriostatic water or sterile PBS; gently swirl (avoid vigorous shaking).
3. Stock concentration example: 20–50 mg/mL total complex.
4. Aliquot immediately → store at –80 °C. Thawed aliquots stable 2–8 °C for 7–14 days.

Typical research concentrations:

• In-vitro: 0.1 nM – 10 μM (most active 1–100 nM)
• In-vivo: 0.5–5 mg/kg (systemic) or 10–200 μg/cm² (localized/topical)

Common routes: subcutaneous, intradermal, topical application, or direct addition to culture media.

Research Applications of GHK-Cu 100mg Copper Peptide

• Chronic non-healing wounds & diabetic ulcers
• Burn injury and hypertrophic/keloid scar models
• Skin aging & photoaging reversal studies
• Tendon/ligament matrix remodeling & tendinopathy analogs
• Hair follicle cycling and alopecia areata models
• Pulmonary fibrosis and liver fibrosis analogs
• Post-surgical adhesion prevention
• Radiation dermatitis and mucositis protection

Key endpoints where GHK-Cu 100mg Copper Peptide consistently excels:

• Increased collagen I/III deposition & organization
• Reduced scar elevation index & fibrosis markers
• Accelerated re-epithelialization & granulation tissue formation
• Decreased inflammatory cytokines (TNF-α, IL-6, TGF-β1)
• Enhanced angiogenesis (CD31, VEGF staining)
• Improved biomechanical properties (tensile strength, elasticity)

Frequently Asked Questions About GHK-Cu 100mg Copper Peptide

Q: Why choose the 100mg vial size for GHK-Cu? A: The GHK-Cu 100mg Copper Peptide format is ideal for chronic protocols, large-animal models, organoid cultures, or extended dose-response studies that require substantial material without frequent reordering.

Q: Does GHK-Cu 100mg Copper Peptide require special handling due to the copper? A: No special precautions beyond standard peptide handling; copper remains tightly bound and stable in the complex. Avoid strong reducing agents during reconstitution.

Q: Is GHK-Cu 100mg Copper Peptide stable after reconstitution? A: Yes—stable 7–14 days at 2–8 °C when aliquoted; freeze for longer storage. Blue color may fade slightly over time but potency remains intact.

Q: Can it be combined with other peptides in the same experiment? A: Yes—commonly paired with BPC-157, TB-500, KPV, or growth factors for synergistic matrix remodeling and anti-inflammatory effects.

Q: How to verify copper content and peptide purity? A: Each batch COA includes both peptide purity (HPLC/MS) and copper stoichiometry (ICP-MS or equivalent).

One Question That Could Shape Your Next Regeneration or Scar Study

If you could deploy a multi-mechanism matrix remodeler like GHK-Cu 100mg Copper Peptide right now in your chronic wound or fibrosis model, which pathological feature—excessive collagen deposition, persistent inflammation, poor vascularization, or delayed re-epithelialization—would you target first, and what single histological or biomechanical endpoint would you use to prove reversal?

Your answer might become the cornerstone of your next high-impact publication.

In summary, GHK-Cu 100mg Copper Peptide from Cali BioLab Peptides is one of the most versatile and extensively documented regenerative research compounds available today. With large-format supply, exceptional purity, reliable quality control, and decades of preclinical evidence across skin, connective tissue, and fibrosis models, it remains an essential tool for investigations into matrix remodeling, scarless healing, and age-reversal biology.

Order your GHK-Cu 100mg Copper Peptide today at Cali BioLab Peptides and explore the full spectrum of copper-peptide regenerative potential with confidence.